f Pharmaceutical Science Strategies for Drug Therapeutic Advancement: Drug Discovery and Development (Part 2)

References

1. PathakR. ChandraP. SachanN. Unravelling peptic ulcers: Comprehensive insights into etiology, diagnosis, screening techniques, and treatment.Curr. Pharm. Des.202531262065208410.2174/0113816128310979240828102727 39318209
   [Google Scholar]
2. NarayananP.L. VellapandianC. Screening of optimal phytoconstituents through in silico docking, toxicity, pharmacokinetic, and molecular dynamics approach for fighting against polycystic ovarian syndrome.Curr Pharm202531262085210410.2174/0113816128330398241015115043 39513314
   [Google Scholar]
3. GupthaP.M. PaleiN.N. VijayarajS. MohantaB.C. MurugesanV. Formulation, optimization, and ex vivo permeation study of ritonavir-loaded solid lipid nanoparticles.Curr. Pharm. Des.202531262105211610.2174/0113816128329768241230071303 40012287
   [Google Scholar]
4. SharmaS. ChauhanS. SharmaB.K. CP-MLR/PLS-guided quantitative structure-activity relationship study on the derivatives of benzimidazolone as H3-antihistaminic agents.Curr. Pharm. Des.202531262117212810.2174/0113816128330939250313060926 40207820
   [Google Scholar]
5. PilaniaP. SinghP. QSAR and molecular docking studies on uracil-based benzoic acid and ester derivatives to explore novel dipeptidyl peptidase-4 inhibitors.Curr. Pharm. Des.202531262129214310.2174/0113816128331664250206113701 40103460
   [Google Scholar]